MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Short-term marketablesecurities$101,208K Cash and cashequivalents$8,356K Prepaid expenses andother current assets$3,840K Total current assets$113,404K Long-term marketablesecurities$36,741K Other long-termassets$1,530K Operating leaseright-of-use assets$447K Property and equipment,net$250K Total assets$152,372K Total liabilities andstockholders' equity$152,372K Total stockholders'equity$148,085K Total liabilities$4,287K Accumulated deficit-$303,449K Additional paid-in capital$451,372K Total currentliabilities$4,071K Operating leaseliabilities, net of current...$216K Accumulated othercomprehensive loss$157K Common stock, 0.0001par value...$5K Accrued expenses andother current...$2,948K Accounts payable$860K Operating leaseliabilities$263K Accrued externalresearch and development...$1,318K Accrued payroll andrelated expenses$984K Accrued professionalfees$533K Other accruedexpenses and current...$113K
Balance Sheet

Climb Bio, Inc. (CLYM)

Climb Bio, Inc. (CLYM)

source: myfinsight.com